Open an account

Aflac

AFL · NYSE

$120.27+$1.60 (+1.35%)TodayMarket closed ·
Prev close $118.67

About AFL

Aflac, Inc. is a holding company, which engages in the provision of financial protection services. The company is headquartered in Columbus, Georgia and currently employs 12,716 full-time employees. The Company’s principal business is supplemental health and life insurance products. The Company’s segments include Aflac Japan, which includes Aflac Life Insurance Japan (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC) and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The firm designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.

Employees
12,716
Headquarters
Columbus, Georgia
Listed
Jun 15, 1974
Sector
Financials
Industry
Insurance
Website
aflac.com

AFL key statistics

Market cap
60.30B
Price-earnings ratio
12.76
Dividend yield
1.99%
Average volume
1.70M
Volume
1.31M
Open price
$119.61
High today
$120.65
Low today
$116.76
52 Week high
$130.22
52 Week low
$105.43

Aflac (AFL) at a glance

Aflac (AFL) last traded at $120.27, with a market cap of 60.30B, a price-to-earnings ratio of 12.76 and a dividend yield of 1.99%.

Today the stock has traded between $116.76 and $120.65. The current price is 3.0% above the day's low and 0.3% below its high.

Volume so far is 1.31M shares, below the average of 1.70M shares a day.

Over the past year Aflac has ranged from $105.43 to $130.22, and now sits 60% of the way up that range.

Aflac met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $1.75 per share against an estimate of $1.79.

The average analyst price target is $118.29, 1.6% below the current price, from 17 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

12%of 17 analyst ratings say Buy
  • Buy11.8%
  • Hold64.7%
  • Sell23.5%
Price target · 18 analystsAvg $118.29
Low
$78.36
Now
$120.27
High
$144.90

AFL earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 23.2% on average.

  1. Q3 FY24: reported $2.16 per share against an estimate of $1.70
  2. Q4 FY24: reported $1.57 per share against an estimate of $1.64
  3. Q1 FY25: reported $1.66 per share against an estimate of $1.69
  4. Q2 FY25: reported $1.78 per share against an estimate of $1.72
  5. Q3 FY25: reported $2.49 per share against an estimate of $1.79
  6. Q4 FY25: reported $1.57 per share against an estimate of $1.71
  7. Q1 FY26: reported $1.75 per share against an estimate of $1.83
  8. Q2 FY26: reported $1.75 per share against an estimate of $1.79

AFL news

  • Press releaseBusiness Wire

    AM Best Affirms Credit Ratings of Aflac Incorporated and Its Subsidiaries

  • Press releasePRNewswire

    Burnout, misinformation and financial vulnerability driving critical choices across American workforce, with Gen Z at the epicenter

  • Press releasePRNewswire

    1 in 3 U.S. workers do not have a legacy plan in place

  • Press releasePRNewswire

    Aflac Incorporated to Release Third Quarter Results and CFO Video Update on November 4, 2026 and Host Webcast on November 5, 2026

  • Press releasePRNewswire

    Former baseball and football star Brian Jordan and Aflac President Virgil Miller join forces to show love and care to children and families at SSM Health Cardinal Glennon Children's Hospital in St. Louis

  • Press releasePRNewswire

    Aflac + Rachel Zoe make bold fashion statement to prompt Americans to Check for Cancer

  • Avi Kapoor

    Jim Cramer Recommends Buying This Communication Services Stock, Calling It ‘Amazing’

  • Press releasePRNewswire

    Aflac commemorates National Childhood Cancer and Sickle Cell Disease Awareness Month

Similar companies

Companies in the same industry as Aflac

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.